Bruker and 3M Sign Exclusive Patent License Agreement

News   Jun 04, 2013

 
Bruker and 3M Sign Exclusive Patent License Agreement
 
 
 

RELATED ARTICLES

Pathway in Neurons may Contribute to Neurodegenerative Disease

News

Pathway has received attention as potential drug target.

READ MORE

Human Minibrains reveal the Effects of Psychedelic Substances

News

By employing mass spectrometry-based proteomics to analyze cerebral organoids, scientists identified the effects of psychedelic substances in the brain.

READ MORE

Osteoporosis Treatments Advanced by Mass Spectrometry Techniques

News

Using advanced mass spectrometry technology, scientists have developed a molecular model that may provide a new framework for improving the design of osteoporosis treatments.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE